Suppr超能文献

液体活检蛋白质组学指导的代谢物治疗延缓视网膜神经退行性变。

Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration.

机构信息

Omics Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, United States.

Omics Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, United States; Medical Scientist Training Program, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, United States.

出版信息

EBioMedicine. 2020 Feb;52:102636. doi: 10.1016/j.ebiom.2020.102636. Epub 2020 Feb 3.

Abstract

BACKGROUND

Neurodegenerative diseases are incurable disorders caused by progressive neuronal cell death. Retinitis pigmentosa (RP) is a blinding neurodegenerative disease that results in photoreceptor death and progresses to the loss of the entire retinal network. We previously found that proteomic analysis of the adjacent vitreous served as way to indirectly biopsy the retina and identify changes in the retinal proteome.

METHODS

We analyzed protein expression in liquid vitreous biopsies from autosomal recessive (ar)RP patients with PDE6A mutations and arRP mice with Pde6ɑ mutations. Proteomic analysis of retina and vitreous samples identified molecular pathways affected at the onset of photoreceptor death. Based on affected molecular pathways, arRP mice were treated with a ketogenic diet or metabolites involved in fatty-acid synthesis, oxidative phosphorylation, and the tricarboxylic acid (TCA) cycle.

FINDINGS

Dietary supplementation of a single metabolite, ɑ-ketoglutarate, increased docosahexaeonic acid levels, provided neuroprotection, and enhanced visual function in arRP mice. A ketogenic diet delayed photoreceptor cell loss, while vitamin B supplementation had a limited effect. Finally, desorption electrospray ionization mass spectrometry imaging (DESI-MSI) on ɑ-ketoglutarate-treated mice revealed restoration of metabolites that correlated with our proteomic findings: uridine, dihydrouridine, and thymidine (pyrimidine and purine metabolism), glutamine and glutamate (glutamine/glutamate conversion), and succinic and aconitic acid (TCA cycle).

INTERPRETATION

This study demonstrates that replenishing TCA cycle metabolites via oral supplementation prolongs retinal function and provides a neuroprotective effect on the photoreceptor cells and inner retinal network.

FUNDING

NIH grants [R01EY026682, R01EY024665, R01EY025225, R01EY024698, R21AG050437, P30EY026877, 5P30EY019007, R01EY018213, F30EYE027986, T32GM007337, 5P30CA013696], NSF grant CHE-1734082.

摘要

背景

神经退行性疾病是由进行性神经元细胞死亡引起的不可治愈的疾病。色素性视网膜炎(RP)是一种致盲性神经退行性疾病,导致光感受器死亡,并进展为整个视网膜网络的丧失。我们之前发现,对玻璃体的蛋白质组学分析可作为间接对视网膜进行活检的方法,并可识别视网膜蛋白质组中的变化。

方法

我们分析了常染色体隐性(ar)RP 患者 PDE6A 突变和 arRP 小鼠 Pde6ɑ 突变的玻璃体活检中蛋白质的表达。视网膜和玻璃体样本的蛋白质组分析鉴定了在光感受器死亡开始时受影响的分子途径。基于受影响的分子途径,用生酮饮食或参与脂肪酸合成、氧化磷酸化和三羧酸(TCA)循环的代谢物对 arRP 小鼠进行治疗。

结果

单一代谢物α-酮戊二酸的饮食补充增加了二十二碳六烯酸的水平,为 arRP 小鼠提供了神经保护并增强了视觉功能。生酮饮食延缓了光感受器细胞的丧失,而维生素 B 的补充作用有限。最后,对α-酮戊二酸处理的小鼠进行解吸电喷雾电离质谱成像(DESI-MSI)显示,代谢物的恢复与我们的蛋白质组学发现相关:尿嘧啶、二氢尿嘧啶和胸腺嘧啶(嘧啶和嘌呤代谢)、谷氨酰胺和谷氨酸(谷氨酰胺/谷氨酸转化)以及琥珀酸和富马酸(TCA 循环)。

解释

这项研究表明,通过口服补充 TCA 循环代谢物可延长视网膜功能,并对光感受器细胞和内层视网膜网络提供神经保护作用。

资金

美国国立卫生研究院(NIH)资助[R01EY026682、R01EY024665、R01EY025225、R01EY024698、R21AG050437、P30EY026877、5P30EY019007、R01EY018213、F30EYE027986、T32GM007337、5P30CA013696]、美国国家科学基金会(NSF)资助 CHE-1734082。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ade/7005447/acd53b47cc4b/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验